B-CELL MALIGNANCY

Clinical trials for B-CELL MALIGNANCY explained in plain language.

Never miss a new study

Get alerted when new B-CELL MALIGNANCY trials appear

Sign up with your email to follow new studies for B-CELL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

New drug combo shows promise for Hard-to-Treat blood cancers

Disease control Completed

This early-stage study tested a combination of two drugs, acalabrutinib and ACP-319, in 40 people with B-cell cancers such as non-Hodgkin lymphoma, multiple myeloma, and B-cell acute lymphoblastic leukemia. The goal was to check safety and how well the drugs work together. Partic…

Matched conditions: B-CELL MALIGNANCY

Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC

B-CELL MALIGNANCY

Get alerted when new B-CELL MALIGNANCY trials appear

New drug combo shows promise for Hard-to-Treat blood cancers